Literature DB >> 3413736

Detection of small inhibitory effects of acetylsalicylic acid (ASA) by platelet impedance aggregometry in whole blood.

P Sathiropas1, G A Marbet, S Sahaphong, F Duckert.   

Abstract

Our investigations have demonstrated on 10 volunteers receiving either 500 mg or 100 mg acetylsalicylic acid (ASA) that a low collagen concentration (1 microgram/ml) can best detect the aggregation defect caused by ASA. With the impedance aggregometry the mean inhibition reaches 82% and 52% with 500 mg and 100 mg ASA, respectively. Collagen at higher concentration (3 micrograms/ml) as well as ADP 10 and 25 mumol/l are less sensitive, less than 25% inhibition was recorded. These results suggest that a 1 microgram/ml concentration of collagen is adequate for the control of the ASA effect up to 6 days after intake of 100 mg. Furthermore, the von Willebrand factor (vWF) dependent platelet aggregation induced by 0.6 and 1.0 mg/ml ristocetin was clearly diminished after ASA. Therefore, a ristocetin screening test in whole blood for vWF disorder is possibly distorted when the test is performed within 6 days from ASA administration.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3413736     DOI: 10.1016/0049-3848(88)90282-4

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  3 in total

1.  Research pointers: Platelet responsiveness to aspirin in patients with hyperlipidaemia.

Authors:  Maribeth Friend; Ivana Vucenik; Michael Miller
Journal:  BMJ       Date:  2003-01-11

2.  Aspirin as a risk factor for hemorrhage in patients with head injuries.

Authors:  M A Reymond; G Marbet; E W Radü; O Gratzl
Journal:  Neurosurg Rev       Date:  1992       Impact factor: 3.042

3.  Significance of plasma D-dimer in relation to the severity of atherosclerosis among patients evaluated by non-invasive indices of cardio-ankle vascular index and carotid intima-media thickness.

Authors:  Shigeru Hayashi
Journal:  Int J Hematol       Date:  2010-06-18       Impact factor: 2.490

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.